Methdilazine

This page contains recent news articles, when available, and an overview of Methdilazine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Methdilazine
(when available)

Pharmacology and use:
In allergic reactions an allergen interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once the mast cell-antibody-antigen complex is formed, a complex series of events occurs that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Once released, histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H1-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Methdilazine is a histamine H1 antagonist. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies. Used for the symptomatic relief of hypersensitivity reactions and particularly for the control of pruritic skin disorders

Mechanism Of Action:
Methdilazine binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.

News Articles on Methdilazine

Illinois Administrative Code - 77 Ill. Adm. Code 790.6020 METHDILAZINE...  -  Aug 10, 2005
77 Ill. Adm. Code 790.6020 METHDILAZINE HYDROCHLORIDE (Repealed) Repealed. (Source: Repealed at 16 Ill. Reg. 12913, effective August 10, 1992) ... Pay-Per-View - Illinois Administrative Code - Loislaw

Antihistamines, Phenothiazine-derivative (Systemic).(Drug overview)  -  May 1, 2006
Methdilazine, promethazine, and trimeprazine have not been studied in pregnant women. In animal studies, promethazine has not been shown to cause birth ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Antihistamines, Phenothiazine-derivative (Systemic).  -  Oct 27, 2005
Methdilazine, promethazine, and trimeprazine have not been studied in pregnant women. In animal studies, promethazine has not been shown to cause birth ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Georgia Code - 16-13-71. (a) A "dangerous drug" means any drug other ...  -  Aug 4, 2005
...(579) Methazolamide; (580) Methdilazine; (581) Methenamine hippurate; (582) Methenamine mandelate; (583) Methenamine sulfosalicylate; (584) Methicillin; ... Pay-Per-View - Georgia Code - Loislaw

Brand Names/Synonyms:
Methdilazine is also known by the following brand names and/or synonymsBristaline; Dilosyn; Disyncram; Disyncran; MJ 5022; Md; Methdilazine; Methdilazine Hcl; Methdilazine Hydrochloride; Methdilazine Monohydrochloride; Methdilazine [Usan:Ban:Inn]; Methdilazinum [Inn-Latin]; Methilazine Hydrochloride; Methodilazine; Metodilazina [Inn-Spanish]; NCI-C60720; Product 5022; Tacaryl; Tacaryl Hydrochloride; Tacazyl; Tacryl

Drug Category:
Methdilazine is categorized under the following by the FDA: Antihistamines; ATC:R06AD04

Dosage Forms:
Syrup, Tablets, Chewable tablets

Absorption:
Well absorbed in the digestive tract.

Interactions:
Not Available



Chemical IUPAC Name:
10-[(1-methylpyrrolidin-3-yl)methyl]-10H-phenothiazine





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy